AARTI DRUGS
|
The Current P/E Ratio of AARTI DRUGS is 22.94.
Share Price | ₹474.4 | Sep 04,2025 |
Market Cap | ₹4,330.8 Cr | |
Earnings-TTM | ₹188.8 Cr | TTM-Consolidated Results |
Price/Earnings | 22.94x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of AARTI DRUGS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹4,330.8 Cr] as on Sep 04,2025
(/) Earnings [ ₹188.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 22.94x ]
Thus, for AARTI DRUGS , the investors are currently willing to pay 22.94 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AARTI DRUGS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of AARTI DRUGS over the last five years.
Historical PE (Price/Earnings) ratio chart of AARTI DRUGS
PE Ratio Performance Analysis for AARTI DRUGS
- AARTI DRUGS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 17.32x.
- AARTI DRUGS 's operated at median p/e ratio of 19.37x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AARTI DRUGS 's p/e ratio peaked in Mar2024 at 23.27x.
- AARTI DRUGS 's p/e ratio hit its five-year low in Mar2020 of 2.08x.
How does AARTI DRUGS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
AARTI DRUGS | 188.79 | 22.94 | 4,330.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 36.47 | 379,659.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 70.64 | 162,886.0 |
CIPLA LTD | 5,406.81 | 23.57 | 127,435.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.80 | 121,719.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.27 | 104,610.0 |
MANKIND PHARMA LTD | 1,905.51 | 55.59 | 105,918.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.96 | 101,831.0 |
LUPIN LTD | 3,722.18 | 23.80 | 88,583.0 |
AUROBINDO PHARMA LTD | 3,417.93 | 17.59 | 60,127.5 |
ABBOTT INDIA LTD | 1,452.29 | 47.11 | 68,417.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs AARTI DRUGS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.59x |
Max industry PE | 70.64x |
Median industry PE | 23.80x |
Average industry PE | 36.25x |
You may also like the below Video Courses